Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Sykes Says: Some Suppressive SEC Short Selling Scrap Stocks Suckas!
Oct 02, 2008 12:20 PM
- Eight White Hot Stocks You Should Know About
Sep 29, 2008 10:58 AM
- Indevus Pharmaceuticals, Inc. : The Subway Stock Trader Pick of the Day
Sep 26, 2008 12:30 PM
- TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Alseres Pharmaceuticals, Inc. Raises $5 Million
Jul 01, 2008 09:00 AM
- Indevus Gets Nonapprovable Letter On Testosterone Drug
Jun 30, 2008 11:14 AM
- Indevus Gets Approvable Letter On Testosterone Drug
Jun 30, 2008 11:14 AM
- Obagi Medical rises on analyst 'Buy' rating and Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
May 21, 2008 09:29 AM
- Obagi Medical rises on analyst 'Buy' rating and Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
May 21, 2008 09:29 AM
- NASDAQ Technical Picture - Narrow Range Day
May 21, 2008 02:00 AM
- Fed cut rally- Day Two
Sep 19, 2007 10:38 AM
- Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
Nov 25, 2008 07:40 AM
- Indevus Pharmaceuticals to Announce Fiscal 2008 Financial Results on Tuesday, November 25, 2008
Nov 18, 2008 08:02 AM
- Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
Oct 28, 2008 08:15 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: DNDN, SPSN, SONS, CEGE, IDEV, ARDM
Oct 07, 2008 09:02 AM
- Indevus Announces Initiation of Phase III Clinical Trial of Octreotide Implant for Acromegaly
Sep 30, 2008 08:01 AM
- Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Sep 26, 2008 10:30 AM
- Indevus and FDA Agree on Path Forward for NEBIDO(R)
Sep 26, 2008 09:01 AM
- Indevus Pharmaceuticals Scheduled to Present at 2008 UBS Global Life Sciences Conference
Sep 16, 2008 08:03 AM
- Indevus Announces Private Placement of $105 Million of Non-Recourse Notes
Aug 26, 2008 11:43 AM
- Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
Aug 22, 2008 08:00 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
IDEV
|
Compare to S&P
|
| YTD |
-66.62 %
|
-0.01 %
|
| 4 Weeks |
-7.57 %
|
1.14 %
|
| 12 Weeks |
17.17 %
|
65.79 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 28.00 %
|
|
EPS Growth in Last Year: -50.00 %
|
|
Sales Growth in Last Quarter: 14.26 %
|
|
Sales Growth in Last Quarter: -20.83 %
|
|
|
